Efficacy of Anti Hyperglycemic Therapies and the Influence of Baseline Hemoglobin A1C: A Meta-Analysis of the Liraglutide Development Program
Year: 2011
Type: review
Source: Endocrine Practice
DOI: 10.4158/ep.17.6.906
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Amgen, GlaxoSmithKline, Eisai, Novo Nordisk
OpenAlex ID: W2022936370
